Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

BACKGROUND: Patients with pulmonary arterial hypertension who achieve a six-minute walk distance of 380–440 m may have improved prognosis. Using the randomized controlled trial of macitentan in pulmonary arterial hypertension (SERAPHIN), the association between six-minute walk distance and long-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza, Rogério, Channick, Richard N., Delcroix, Marion, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Le Brun, Franck-Olivier, Mehta, Sanjay, Perchenet, Loïc, Pulido, Tomás, Sastry, B. K. S., Sitbon, Olivier, Torbicki, Adam, Rubin, Lewis J., Simonneau, Gérald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873992/
https://www.ncbi.nlm.nih.gov/pubmed/29590122
http://dx.doi.org/10.1371/journal.pone.0193226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873992/
https://www.ncbi.nlm.nih.gov/pubmed/29590122
http://dx.doi.org/10.1371/journal.pone.0193226

Ejemplares similares